Interpretable artificial intelligence model for predicting heart failure severity after acute myocardial infarction
- PMID: 40355836
- PMCID: PMC12067671
- DOI: 10.1186/s12872-025-04818-1
Interpretable artificial intelligence model for predicting heart failure severity after acute myocardial infarction
Abstract
Background: Heart failure (HF) after acute myocardial infarction (AMI) is a leading cause of mortality and morbidity worldwide. Accurate prediction and early identification of HF severity are crucial for initiating preventive measures and optimizing treatment strategies. This study aimed to develop an interpretable artificial intelligence (AI) model for HF severity prediction using multidimensional clinical data.
Methods: This study included data from 1574 AMI patients, including medical history, clinical features, physiological parameters, laboratory test, coronary angiography and echocardiography results. Both deep learning (TabNet, Multi-Layer Perceptron) and machine learning (Random Forest, XGboost) models were employed in constructing model. Additionally, the Shapley Additive Explanation (SHAP) method was used to elucidate clinical factors importance and enhance model interpretability. A web platform ( https://prediction-killip-gby.streamlit.app/ ) was also developed to facilitate clinical application.
Results: Among the models, TabNet demonstrated the best performance, achieving an AUROC of 0.827 for KILLIP four-class classification and 0.831 for KILLIP binary classification. Key clinical factors such as GRACE score, NT-pro BNP, and TIMI score were highly correlated with KILLIP classification, aligning with established clinical knowledge.
Conclusions: By leveraging easily accessible multidimensional data, this model enables accurate early prediction and personalized diagnosis of HF risk and severity following AMI. It supports early clinical intervention and improves patient outcomes, offering significant clinical application value.
Clinical trial number: Not applicable.
Keywords: Acute myocardial infarction; Artificial intelligence; Deep learning; Heart failure.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by the Ethics Committee of Xuanwu Hospital, Capital Medical University with the approval document number (2022–129) and was processed according to the principles of the Declaration of Helsinki. All enrolled patients signed informed consent forms. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures







Similar articles
-
Predicting the risk of heart failure after acute myocardial infarction using an interpretable machine learning model.Front Cardiovasc Med. 2025 Jan 24;12:1444323. doi: 10.3389/fcvm.2025.1444323. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 39925976 Free PMC article.
-
A systematic comparison of short-term and long-term mortality prediction in acute myocardial infarction using machine learning models.BMC Med Inform Decis Mak. 2025 Jun 5;25(1):208. doi: 10.1186/s12911-025-03052-1. BMC Med Inform Decis Mak. 2025. PMID: 40474184 Free PMC article.
-
Application of machine learning to predict the occurrence of arrhythmia after acute myocardial infarction.BMC Med Inform Decis Mak. 2021 Nov 2;21(1):301. doi: 10.1186/s12911-021-01667-8. BMC Med Inform Decis Mak. 2021. PMID: 34724938 Free PMC article.
-
Evaluation of machine learning methods for prediction of heart failure mortality and readmission: meta-analysis.BMC Cardiovasc Disord. 2025 Apr 7;25(1):264. doi: 10.1186/s12872-025-04700-0. BMC Cardiovasc Disord. 2025. PMID: 40189534 Free PMC article.
-
Benchmarking of Machine Learning classifiers on plasma proteomic for COVID-19 severity prediction through interpretable artificial intelligence.Artif Intell Med. 2023 Mar;137:102490. doi: 10.1016/j.artmed.2023.102490. Epub 2023 Jan 18. Artif Intell Med. 2023. PMID: 36868685 Free PMC article. Review.
Cited by
-
Nonlinear association between visceral fat metabolism score and heart failure: insights from LightGBM modeling and SHAP-Driven feature interpretation in NHANES.BMC Med Inform Decis Mak. 2025 Jul 1;25(1):223. doi: 10.1186/s12911-025-03076-7. BMC Med Inform Decis Mak. 2025. PMID: 40597284 Free PMC article.
References
-
- Hernandez AF, Udell JA, Jones WS, Anker SD, Petrie MC, Harrington J, Mattheus M, Seide S, Zwiener I, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chen Y, Chopra VK, Figtree A, Ge G, Goodman JG, Gotcheva S, Goto N, Gasior S, Jamal T, Januzzi W, Jeong JL, Lopatin MH, Lopes Y, Merkely RD, Parikh B, Parkhomenko PB, Ponikowski A, Rossello P, Schou X, Simic M, Steg D, Szachniewicz PG, van der Meer J, Vinereanu P, Zieroth D, Brueckmann S, Sumin M, Bhatt M, Butler DL. Effect of empagliflozin on heart failure outcomes after acute myocardial infarction: insights from the EMPACT-MI trial. Circulation. 2024;149(21):1627–38. 10.1161/CIRCULATIONAHA.124.069217. - PMC - PubMed
-
- Hori Y, Sakakura K, Jinnouchi H, Taniguchi Y, Tsukui T, Hatori M, Kasahara T, Watanabe Y, Yamamoto K, Seguchi M, Fujita H. Determinants of serious in-hospital complications in patients with Killip class 1/2 ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention. Heart Vessels. 2024 Mar;18. 10.1007/s00380-024-02382-w. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous